Moderna revenue triples on soaring covid-19 vaccine sales
2 years, 8 months ago

Moderna revenue triples on soaring covid-19 vaccine sales

Live Mint  

Moderna Inc.’s first-quarter sales tripled from a year ago on the back of its Covid-19 vaccine. The biotechnology company’s revenue topped $6 billion in the period ended March 31, beating analyst expectations, driven almost entirely by sales of its mRNA-based vaccine. The Cambridge, Mass.-based company’s so-called Spikevax shot received full approval from the Food and Drug Administration in January, making it the second vaccine to do so after one from Pfizer Inc. and BioNTech SE. The company said Wednesday that it aims to have four vaccine programs in late-stage studies in the second quarter, including its Omicron-specific booster and a seasonal flu shot.

Quarter Vaccine Moderna Revenue  pfizer  companys  received  vaccine  covid19  quarter  second  share  triples  soaring  billion  moderna  revenue  shot  sales

History of this topic

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
4 weeks ago

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind

CNN  

A version of this story appeared in CNN Business’ Nightcap newsletter. Moderna’s Covid vaccine remains the primary driver of its revenue, and its other vaccine, one for RSV, is “not likely to be a major player.” Unsurprisingly, then, the short-sellers are piling in hard. “Moderna’s declining stock price, rising short interest, and increased implied volatility reveal an evolving risk narrative,” …

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
55 years ago

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

Wired  

The US government will pay Moderna $176 million to develop an mRNA vaccine against a pandemic influenza—an award given as the highly pathogenic bird flu virus H5N1 continues to spread widely among US dairy cattle. In its own announcement on Tuesday, Moderna noted that it began a Phase 1/2 trial of a pandemic influenza virus vaccine last year, which included …

US awards Moderna 176 mln USD for vaccine development amid bird flu outbreak
6 months, 1 week ago

US awards Moderna 176 mln USD for vaccine development amid bird flu outbreak

China Daily  

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. LOS ANGELES - The US government on Tuesday announced a 176-million-US-dollar investment in biotech company Moderna to develop a vaccine against bird flu as concerns escalate over a multi-state outbreak in dairy cows. This initiative comes as the ongoing outbreak of influenza …

Anticipating a major bird flu crisis, the U.S. government just awarded $176 million for a vaccine
6 months, 1 week ago

Anticipating a major bird flu crisis, the U.S. government just awarded $176 million for a vaccine

Salon  

In the ongoing waves of bird flu outbreaks, with the virus spreading to more than 141 herds in 12 states, the risk of another full-blown pandemic like COVID-19 is becoming a distinct possibility. In preparation for just such a disaster, the U.S. government will pay pharmaceutical company Moderna $176 million to develop a vaccine that protects against the H5N1 virus. …

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
6 months, 1 week ago

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

Associated Press  

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about cases in dairy cows across the country, federal officials announced Tuesday. Moderna already has a bird flu vaccine in very early-stage testing that uses the same mRNA …

Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought
1 year, 2 months ago

Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought

Associated Press  

Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up
1 year, 5 months ago

Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up

Associated Press  

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023. Pfizer recorded no U.S. sales of its treatment, Paxlovid, in the recently completed quarter, as the company shifts to selling the pills on the commercial market after contracting with the government. Sales of the …

Pfizer tops Q1 forecasts; vaccine sales slide as expected
1 year, 8 months ago

Pfizer tops Q1 forecasts; vaccine sales slide as expected

Associated Press  

Pfizer beat first-quarter forecasts as revenue took an expected dip, but the drugmaker predicted a sales rally later this year. The company said Tuesday that it also expects significantly lower sales from its vaccine and COVID-19 treatment, Paxlovid, in the second quarter compared to the first. Plus Pfizer also expects a revenue boost later this year from new product launches …

Moderna expects to price its COVID vaccine at about $130 in the US
1 year, 9 months ago

Moderna expects to price its COVID vaccine at about $130 in the US

Live Mint  

Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move to the private sector from the government, the company’s president Stephen Hoge said in an interview on Monday. “There are different customers negotiating different prices right now, which is why it's a little bit complicated,” Hoge said ahead of …

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit
1 year, 10 months ago

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit

Associated Press  

Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment. Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots. Researchers are testing how Moderna’s potential vaccine and Merck’s immunotherapy Keytruda work in improving …

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them
1 year, 11 months ago

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

LA Times  

Doses of the Moderna COVID-19 vaccine wait to be administered at a clinic. That included a research grant of almost $1 billion from the government’s Biomedical Advanced Research and Development Authority, or BARDA, through 2020, plus a $1.5-billion federal purchase guarantee in 2020 for COVID vaccines before testing was even completed — a deal that materially reduced Moderna’s financial risks …

Moderna will hike Covid shot price from $26 to $130 to match rival Pfizer's, CEO tells DailyMail.com
2 years ago

Moderna will hike Covid shot price from $26 to $130 to match rival Pfizer's, CEO tells DailyMail.com

Daily Mail  

Moderna will hike up the price of its Covid shot five-fold to match its rival Pfizer's, DailyMail.com can reveal. CEO Stéphane Bancel said the cost of Moderna's Covid vaccine will be 'going up a little bit' to be priced in the 'same ballpark' as Pfizer's when it goes on the open market this year. Moderna's CEO Stéphane Bancel revealed his …

Merck, Moderna detail potential skin cancer vaccine progress
2 years ago

Merck, Moderna detail potential skin cancer vaccine progress

Associated Press  

Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer. The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed. The drugmakers said a combination of the vaccine and …

Pfizer chief boasts Covid pandemic will be 'multi-billion dollar franchise' for years to come
2 years, 2 months ago

Pfizer chief boasts Covid pandemic will be 'multi-billion dollar franchise' for years to come

Daily Mail  

Pfizer’s chief financial officer has described the Covid pandemic as a 'multi-billion dollar franchise' — and expects profit to continue. The mRNA vaccine, developed with Germany-based BioNTech, will soon become pricier for people without health insurance as government contracts that made the shots free for all Americans are slated to expire Pfizer has raked in $100 billion from selling Covid-19 …

Pfizer rides Paxlovid sales to better-than-expected quarter
2 years, 2 months ago

Pfizer rides Paxlovid sales to better-than-expected quarter

Associated Press  

Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its coronavirus vaccine and top third-quarter expectations. Pfizer executives said Tuesday that vaccine could hit the market late next year, depending on regulatory approvals, and could become another multi-billion dollar sales generator. Overall, Pfizer’s profit jumped 6% to $8.61 billion in the third quarter, and adjusted earnings totaled …

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
2 years, 4 months ago

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

The Hindu  

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. The U.S. Food and Drug Administration granted emergency use authorization for the COVID-19 vaccine first to Pfizer/BioNTech in December 2020, then one week later …

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine
2 years, 4 months ago

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine

ABP News  

Moderna said on Friday it was suing Pfizer and and its German partner BioNTech for copying the "groundbreaking technology" behind its mRNA Covid-19 vaccine. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the company said in a statement. "Moderna expects Pfizer and BioNTech to compensate Moderna …

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement
2 years, 4 months ago

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement

News 18  

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot that has been administered to hundreds of millions around the world. “Moderna believes that Pfizer and BioNTech’s Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology,” the company said …

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement
2 years, 4 months ago

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement

India Today  

Moderna said on Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said …

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine
2 years, 4 months ago

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine

Live Mint  

American pharmaceutical and biotechnology company Moderna has filed a suit in a United States District court against Pfizer and its German partner BioNTech, seeking undetermined damages for patent infringement in the development of the first Covid-19 vaccine. Moderna in a press release informed that they are seeking undetermined monetary damages in the lawsuit filed in the U.S. District Court in …

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech
2 years, 4 months ago

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

Al Jazeera  

Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears. Moderna has said it is suing rival vaccine maker Pfizer and its German partner BioNTech, citing infringement on its patents in developing the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. “Moderna …

Moderna sues Pfizer and BioNTech, alleging they copied its COVID-19 vaccine technology
2 years, 4 months ago

Moderna sues Pfizer and BioNTech, alleging they copied its COVID-19 vaccine technology

LA Times  

Moderna has accused Pfizer and BioNTech of copying its technology to make their COVID-19 vaccine. Moderna said Friday that Pfizer and Germany-based BioNTech’s COVID-19 vaccine, Comirnaty, infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax. Pfizer spokeswoman Pam Eisele said the company had not fully reviewed Moderna’s lawsuit but was surprised by it, …

COVID-19 vaccine sales push Moderna past expectations in Q2
2 years, 5 months ago

COVID-19 vaccine sales push Moderna past expectations in Q2

Associated Press  

Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street’s second-quarter forecasts. Moderna shares surged Wednesday after the company also announced another $3 billion share buyback plan. Moderna’s vaccine sales in the second quarter represent a drop from the nearly $6 billion that the vaccine brought in during the year’s first quarter, when a virus surge through the United States pushed …

Moderna Announces Positive Results for Omicron Vaccine
2 years, 7 months ago

Moderna Announces Positive Results for Omicron Vaccine

News 18  

US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron. This so-called “bivalent” vaccine was tested in a trial of more than 850 adults, who had all received their first three doses of Moderna’s original Spikevax vaccine. Those who received the bivalent vaccine had significantly higher levels of …

Moderna Delays Covid Vaccine Deliveries to EU by Several Months
2 years, 7 months ago

Moderna Delays Covid Vaccine Deliveries to EU by Several Months

News 18  

Moderna Inc said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early next year. The bloc had also tweaked agreements with Pfizer Inc and German partner BioNTech SE in April to delay vaccine deliveries by three months as it gears up for a potential …

Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged
2 years, 8 months ago

Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged

Al Jazeera  

Pfizer shares fluctuated early Tuesday and were little changed at 9:35am in New York. Pfizer Inc. kept its outlook for annual sales of its Covid-19 vaccine and treatment, disappointing investors who looked for the products to continue driving growth. Through mid-April, Pfizer said it has clinched $32 billion in 2022 contracts for the shot, Comirnaty, and $22 billion for its …

Moderna asks FDA to authorize 4th COVID-19 dose for all adults
2 years, 9 months ago

Moderna asks FDA to authorize 4th COVID-19 dose for all adults

LA Times  

U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later. Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults. In a press release, Moderna said its request for approval for all adults …

Moderna’s profits show why Big Pharma can’t meet our health needs
2 years, 9 months ago

Moderna’s profits show why Big Pharma can’t meet our health needs

Al Jazeera  

Last month, COVID-19 vaccine maker Moderna announced its financial results for 2021. In Spring 2021, the People’s Vaccine Alliance calculated that the COVID-19 vaccines had actually created nine new billionaires, with Bancel topping the nine, and two of Moderna’s founders and Moderna’s chair also appearing on the list. Nearly a year later, in September 2021, the situation had become even …

COVID-19 vaccine sales push Moderna to $12B profit in 2021
2 years, 10 months ago

COVID-19 vaccine sales push Moderna to $12B profit in 2021

Associated Press  

COVID-19 vaccine sales jumped 44% for Moderna in the final quarter of 2021, and the drugmaker expects demand for booster shots to fuel more growth in 2022. Moderna said Thursday that it has signed purchase agreements for about $19 billion in sales for 2022 with options for an additional $3 billion that would cover any updated boosters the company is …

Pfizer’s COVID sales to top $50bn this year, investors want more
2 years, 11 months ago

Pfizer’s COVID sales to top $50bn this year, investors want more

Al Jazeera  

CEO Albert Bourla says final sales for COVID-19 antiviral Paxlovid could be “way bigger” than forecasts. Pfizer Inc said on Tuesday it expects 2022 sales of its COVID-19 vaccine and antiviral pill to top $54bn, but that fell short of lofty Wall Street estimates and its shares were off about 3 percent. Still, Chief Executive Albert Bourla said final sales …

Vaccines pushes Pfizer beyond expectations in final quarter
2 years, 11 months ago

Vaccines pushes Pfizer beyond expectations in final quarter

Associated Press  

COVID-19 vaccine sales boosted Pfizer earnings well past fourth-quarter expectations, but the drugmaker has set a lower-than-expected bar for 2022. Pfizer debuted on Tuesday annual forecasts for both earnings and revenue that fell short of analyst expectations even as the drugmaker expects another robust year of sales from its vaccine, Comirnaty, and its new coronavirus treatment, Paxlovid. Overall, Pfizer forecasts …

US gives full approval to Moderna’s COVID-19 vaccine
2 years, 11 months ago

US gives full approval to Moderna’s COVID-19 vaccine

Associated Press  

WASHINGTON — U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of millions of Americans since its emergency authorization over a year ago. The FDA granted full approval of Pfizer’s vaccine last August. “The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous …

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older
2 years, 11 months ago

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older

Daily Mail  

Moderna's COVID-19 vaccine has received full approval from the Food and Drug Administration for use in adults in the U.S., the company announced Monday. The Moderna COVID-19 vaccine has received full approval for use in adults from the FDA. Only the first two shots of Moderna's vaccine have received approval, and the booster shot remains available of the emergency use …

Who invented covid-19 vaccines? Drugmakers battle over patents
3 years ago

Who invented covid-19 vaccines? Drugmakers battle over patents

Live Mint  

A high-stakes legal battle is taking shape over lucrative patent rights for Covid-19 vaccines, with drug companies pitted against each other and government and academic scientists over who invented what. One dispute stems from Moderna’s decision to deny a National Institutes of Health request to list government scientists as co-inventors on the company’s application for a U.S. patent covering a …

Moderna says booster appears effective against new COVID variant
3 years ago

Moderna says booster appears effective against new COVID variant

Al Jazeera  

The US biotech company Moderna has said that a booster dose of its COVID-19 vaccine appears to protect against the Omicron variant, according to early laboratory tests. The company said on Monday that its current vaccine would continue to be its “first line of defence against Omicron”, although Moderna still plans to develop a vaccine to protect specifically against Omicron. …

Moderna says Omicron vaccine could be ready by early 2022
3 years, 1 month ago

Moderna says Omicron vaccine could be ready by early 2022

Al Jazeera  

Shares of Moderna extended their rally for a second trading session after the drugmaker said it had mobilised hundreds of workers on Thursday to start work on an Omicron jab. Moderna Inc. is having its best two-day rally in a year after the company said a new vaccine to fight the omicron strain of the coronavirus could be ready by …

African Union to buy up to 110 million Moderna COVID vaccines
3 years, 2 months ago

African Union to buy up to 110 million Moderna COVID vaccines

Al Jazeera  

Arrangement brokered in part by the White House which will defer delivery of some doses intended for US to facilitate the deal. The African Union intends to buy up to 110 million doses of COVID-19 vaccines from Moderna Inc in an arrangement brokered in part by the White House which will defer delivery of some doses intended for the United …

The FDA authorizes Moderna and J&J COVID vaccine boosters
3 years, 2 months ago

The FDA authorizes Moderna and J&J COVID vaccine boosters

NPR  

The FDA authorizes Moderna and J&J COVID vaccine boosters Enlarge this image toggle caption Patrick T. Fallon/AFP via Getty Images Patrick T. Fallon/AFP via Getty Images The Food and Drug Administration authorized booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson following unanimous votes by a committee of independent advisers backing the boosters last week. The …

More Covid-19 boosters are on the horizon. But not everyone will need one, experts say
3 years, 2 months ago

More Covid-19 boosters are on the horizon. But not everyone will need one, experts say

CNN  

CNN — Advisers from the US Food and Drug Administration voted unanimously to recommend emergency authorization of a booster dose of Moderna’s Covid-19 vaccine, and a day later did so again for a booster of Johnson & Johnson’s vaccine. Anyone who got the single-shot Johnson & Johnson vaccine “can benefit from a second dose” of it,” Dr. Paul Offit, a …

FDA panel endorses lower-dose Moderna COVID-19 shot for booster
3 years, 2 months ago

FDA panel endorses lower-dose Moderna COVID-19 shot for booster

The Hindu  

U.S. health advisers said on October 14 that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk …

FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups
3 years, 2 months ago

FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups

Huff Post  

LOADING ERROR LOADING U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. Moderna is seeking FDA clearance for a booster used just like Pfizer’s: For people 65 and older, or adults with other health problems, jobs or living situations that put them at increased risk …

FDA panel recommends authorization of Moderna booster shots
3 years, 2 months ago

FDA panel recommends authorization of Moderna booster shots

LA Times  

A vial of the Moderna COVID-19 vaccine at a hospital in Denver. U.S. health advisors said Thursday that some Americans who received the Moderna vaccine should get a half-dose booster. U.S. health advisors said Thursday that some Americans who received Moderna’s COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus. …

Moderna has no plans to share its COVID-19 vaccine recipe
3 years, 2 months ago

Moderna has no plans to share its COVID-19 vaccine recipe

Associated Press  

ROME — Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman said Monday. In an interview with The Associated Press, Noubar Afeyan also reiterated a pledge Moderna made a year ago not to enforce …

Moderna has no plans to share its COVID-19 vaccine recipe
3 years, 2 months ago

Moderna has no plans to share its COVID-19 vaccine recipe

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Moderna has no plans to …

Moderna and Flagship Pioneering: Noubar Afeyan
3 years, 3 months ago

Moderna and Flagship Pioneering: Noubar Afeyan

NPR  

Moderna and Flagship Pioneering: Noubar Afeyan Enlarge this image Kristen Uroda for NPR Kristen Uroda for NPR In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. At a breathtaking pace, Moderna produced a prototype for a COVID-19 vaccine, partnered with …

FDA leans toward authorizing Moderna booster at a half dose
3 years, 3 months ago

FDA leans toward authorizing Moderna booster at a half dose

Live Mint  

The US Food and Drug Administration is leaning toward authorizing half-dose booster shots of the Moderna Inc. coronavirus vaccine, satisfied that it’s effective in shoring up protection, people familiar with the matter said. That would ease supply constraints and potentially blunt criticisms of rich countries beginning sprawling booster campaigns before many nations have given widespread first shots. The booster campaign …

Moderna requests EMA approval for extra Covid vaccine booster shot
3 years, 3 months ago

Moderna requests EMA approval for extra Covid vaccine booster shot

NL Times  

The pharmaceutical company Moderna is seeking approval to offer an additional booster shot of its Covid-19 vaccine. People should get a third shot of that vaccine at least six months after the second shot, Moderna said. Moderna recently conducted research into the effect of the booster shot with its vaccine, called Spikevax. From October 7, several hundred thousand Dutch people …

India won’t buy Pfizer, Moderna Covid doses amid jump in local output: Report
3 years, 3 months ago

India won’t buy Pfizer, Moderna Covid doses amid jump in local output: Report

Live Mint  

New Delhi: India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped. "Earlier, there was a shortage, there was a need," said one of the sources, referring to India's appeal to the companies in April for vaccines when infections exploded and shots …

Discover Related